ParreÑo, Shella .
HRN: 28-45-90 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/03/2026
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
03/03/2026
03/03/2026
IV
1g
Ptor
Stat CS
Checking Initial Appropriateness
03/04/2026
MUPIROCIN 2%, 15G (TUBE)
03/04/2026
03/11/2026
TOPICAL
Pea Sized
OD
S/P Repeat CS
Checking Initial Appropriateness